WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'5601 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 8'6651 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 44'824  45'002  45'165  45'320  45'478  48'746  51'370  49'969 
Births 484  488  490  491  491  403  634  758 
Surviving infants 480  483  485  486  486  397  623  742 
Pop. less than 5 years 2'461  2'487  2'533  2'566  2'525  2'161  3'364  3'717 
Pop. less than 15 years 6'691  6'570  6'496  6'462  6'423  8'267  10'830  10'745 
Female 15-49 years 10'768  10'941  11'116  11'287  11'454  12'706  12'316  12'737 

Number of reported cases

(Click for retrospective incidence data for Ukraine)
Diphtheria
ChartChart
  365  109 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  12'746  1'333  817  6'841 
Mumps
ChartChart
  799  955  26'538 
Pertussis
ChartChart
  2'286  2'937  2'243  4'189 
Polio*
ChartChart
 
Rubella
ChartChart
  1'952  3'667  37'931 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  23  12  36 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ukraine)
Vaccine year result method % card seen                                                
BCG 2011  95  MICS   92  95  90  99 
DTP1 2011  86  MICS   92  42  46 
DTP3 2011  74  MICS   92  76  50  99 
DTP4         
IPV1         
HepB_BD          51  53 
HepB3          46  21 
Hib3          83  26 
JapEnc         
MCV1          79  67  99 
MCV2          54  56  99 
PCV1         
PCV3         
Pol3 2011  73  MICS   92  74  58  99 
Rota1         
RotaC         
Rubella1          79 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ukraine)
BCG
ChartChart
  95  95  95  90  98 
DTP1
ChartChart
  90  90  76  50  99 
DTP3
ChartChart
  76  76  76  50  99 
HepB3
ChartChart
  46  46  46  21 
HepB_BD
ChartChart
  51  51  51  53 
Hib3
ChartChart
  83  83  83  26 
MCV1
ChartChart
  79  79  79  67  99 
MCV2
ChartChart
  54  54  54  56  99 
PCV3
ChartChart
 
Pol3
ChartChart
  74  74  74  58  99 
RotaC
ChartChart
 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; 7 years; Yes
DT 6 years; Yes
DTaPHibIPV 3, 4 months; Yes
DTwP 3, 4, 5, 18 months; Yes
HIB 18 months; Yes
HepB Birth; 1, 6 months; Yes
MMR 18 months; 6 years; Yes
OPV 5, 18 months; 6, 14 years; Yes
Td 14, 18 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR     Yes  Yes  Yes    No 
What years does the MYP cover? number     2009-2015  2009-2015  2009-2015     
Nº of districts with microplans that include activities to raise immunization coverage number             490 

System performance

Total Nº districts in country number             490 
Nº districts with DTP3 coverage >=80% number            
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND       Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR       Yes  Yes    Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       100      100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR       No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.